Clinical trials: Hilar Biliary Strictures, active
Cholangiocarcinoma Non-resectable, Gall Bladder Cancer
Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction
The goal of this clinical randomized controlled trial is to perform primary percutaneous stenting (PPS) in patients with malignant hilar biliary obstruction (MHBO).
- Conditions
- Cholangiocarcinoma Non-resectable, Gall Bladder Cancer, Liver Metastasis, Malignant Hilar Stricture
- Trial name
- TESLA RCT (NCT06671418)
- Testing
- Primary percutaneous stenting (PPS), Endoscopic biliary drainage
- Where
- Netherlands
- Volunteers
- 148 people
- Sponsor
- Erasmus Medical Center
Biliary Disease Tract, Biliary Stenosis
Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis
This is a randomized controlled trial comparing patients with obstructive jaundice due to malignancies of the perihilar area of bile ducts and undergoing both preoperative and palliative biliary drainage.
- Conditions
- Biliary Disease Tract, Biliary Stenosis, Biliary Stents
- Trial name
- SupraBilS (NCT07325877)
- Testing
- ERCP with suprapapillary stent placement, ERCP with transpapillary stent placement
- Volunteers
- 70 people
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona